XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 36 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,353,000 | -8.3% | 300,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,476,000 | -17.0% | 300,000 | 0.0% | 0.00% | -25.0% |
| Q3 2020 | $1,779,000 | +122.9% | 300,000 | 0.0% | 0.00% | +100.0% |
| Q2 2020 | $798,000 | +36.4% | 300,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $585,000 | -72.3% | 300,000 | 0.0% | 0.00% | -60.0% |
| Q4 2019 | $2,115,000 | -28.3% | 300,000 | 0.0% | 0.01% | -28.6% |
| Q3 2019 | $2,949,000 | -14.1% | 300,000 | 0.0% | 0.01% | -12.5% |
| Q2 2019 | $3,432,000 | +13.9% | 300,000 | 0.0% | 0.01% | +14.3% |
| Q1 2019 | $3,012,000 | -40.9% | 300,000 | 0.0% | 0.01% | -50.0% |
| Q4 2018 | $5,100,000 | -3.3% | 300,000 | 0.0% | 0.01% | +16.7% |
| Q3 2018 | $5,274,000 | -7.4% | 300,000 | 0.0% | 0.01% | -29.4% |
| Q2 2018 | $5,694,000 | – | 300,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 4,172,459 | $20,528,000 | 1.31% |
| DELTEC ASSET MANAGEMENT LLC | 693,870 | $3,414,000 | 0.52% |
| Alpine Global Management, LLC | 350,000 | $1,722,000 | 0.35% |
| Redmile Group, LLC | 2,397,441 | $11,795,000 | 0.14% |
| Kamunting Street Capital Management, L.P. | 43,833 | $216,000 | 0.11% |
| IHT Wealth Management, LLC | 250,798 | $1,234,000 | 0.10% |
| SEARLE & CO. | 34,000 | $167,000 | 0.08% |
| GPS Wealth Strategies Group, LLC | 46,025 | $226,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,981,909 | $9,751,000 | 0.08% |
| Gladstone Institutional Advisory LLC | 51,500 | $253 | 0.05% |